4.7 Article

Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination

Journal

NATURE IMMUNOLOGY
Volume 17, Issue 8, Pages 997-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/ni.3488

Keywords

-

Categories

Funding

  1. American Cancer Society [122713-RSG-12-260-01-LIB]
  2. Cancer Prevention Research Institute of Texas [RP160577]
  3. Baylor Charles A. Sammons Cancer Center

Ask authors/readers for more resources

Dysregulated expression of interleukin 17 (IL-17) in the colonic mucosa is associated with colonic inflammation and cancer. However, the cell-intrinsic molecular mechanisms by which IL-17 expression is regulated remain unclear. We found that deficiency in the ubiquitin ligase Itch led to spontaneous colitis and increased susceptibility to colon cancer. Itch deficiency in the T(H)17 subset of helper T cells, innate lymphoid cells and gamma delta T cells resulted in the production of elevated amounts of IL-17 in the colonic mucosa. Mechanistically, Itch bound to the transcription factor ROR-gamma t and targeted ROR-gamma t for ubiquitination. Inhibition or genetic inactivation of ROR-gamma t attenuated IL-17 expression and reduced spontaneous colonic inflammation in Itch(-/-) mice. Thus, we have identified a previously unknown role for Itch in regulating IL-17-mediated colonic inflammation and carcinogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available